INNOVAGE HOLDING CORP (INNV)
US45784A1043 - Common Stock
We assign a fundamental rating of 3 out of 10 to INNV. INNV was compared to 117 industry peers in the Health Care Providers & Services industry. INNV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. INNV is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
INNV had negative earnings in the past year.
In the past year INNV has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: INNV reported negative net income in multiple years.
INNV had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.90%, INNV is doing worse than 60.34% of the companies in the same industry.
With a Return On Equity value of -11.05%, INNV perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.9% | ||
| ROE | -11.05% | ||
| ROIC | N/A |
ROA(3y)-5.54%
ROA(5y)-0.96%
ROE(3y)-9.61%
ROE(5y)4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INNV's Gross Margin of 16.48% is on the low side compared to the rest of the industry. INNV is outperformed by 66.38% of its industry peers.
INNV's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for INNV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.08%
GM growth 5YN/A
2. Health
2.1 Basic Checks
INNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
INNV has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for INNV has remained at the same level compared to a year ago.
2.2 Solvency
INNV has an Altman-Z score of 2.44. This is not the best score and indicates that INNV is in the grey zone with still only limited risk for bankruptcy at the moment.
INNV has a better Altman-Z score (2.44) than 66.38% of its industry peers.
INNV has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of INNV (0.26) is better than 70.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.44 |
ROIC/WACCN/A
WACC8.52%
2.3 Liquidity
A Current Ratio of 1.27 indicates that INNV should not have too much problems paying its short term obligations.
INNV has a Current ratio (1.27) which is in line with its industry peers.
A Quick Ratio of 1.27 indicates that INNV should not have too much problems paying its short term obligations.
INNV has a Quick ratio (1.27) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
INNV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.86%, which is quite good.
The Revenue has been growing slightly by 4.62% in the past year.
The Revenue has been growing slightly by 6.65% on average over the past years.
EPS 1Y (TTM)17.86%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q85.71%
Revenue 1Y (TTM)4.62%
Revenue growth 3Y6.65%
Revenue growth 5YN/A
Revenue growth Q2Q12.77%
3.2 Future
The Earnings Per Share is expected to grow by 37.10% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.86% on average over the next years. This is quite good.
EPS Next Y48.59%
EPS Next 2Y46.67%
EPS Next 3Y37.1%
EPS Next 5YN/A
Revenue Next Year10.1%
Revenue Next 2Y11.11%
Revenue Next 3Y11.86%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
INNV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 86.96, the valuation of INNV can be described as expensive.
INNV's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of INNV to the average of the S&P500 Index (20.72), we can say INNV is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 86.96 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as INNV's earnings are expected to grow with 37.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.67%
EPS Next 3Y37.1%
5. Dividend
5.1 Amount
INNV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INNOVAGE HOLDING CORP
NASDAQ:INNV (5/2/2024, 7:00:18 PM)
After market: 4.08 0 (0%)4.08
+0.2 (+5.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap554.47M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 86.96 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.9% | ||
| ROE | -11.05% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.48% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)17.86%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y48.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.62%
Revenue growth 3Y6.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y